https://www.marketscreener.com/quote/stock/APTOSE-BIOSCIENCES-INC-1410675/news/Aptose-Tuspetinib-Clinical-Data-Selected-for-Oral-Presentation-at-the-2023-ASH-Annual-Meeting-45235559/?utm_source=telegram&utm_medium=social&utm_campaign=share